Joonman Hong

2 months ago | outsourcedpharma.com | Louis Garguilo |Raul P. Lima |inSeption Group |Joonman Hong

Webinar: From Research to Reality: Overcoming CMC Challenges in Cell & Gene TherapyJoin us on February 20th to learn how to overcome manufacturing and regulatory challenges in cell and gene therapy by developing robust CMC strategies, employing Quality by Design, and implementing phase-appropriate GMP processes. This webinar is ideal for small biopharma companies and institutions seeking to bridge research and commercial development effectively. Click here to learn more.

Oct 28, 2024 | cellandgene.com | Tyler Menichiello |Joonman Hong |GC Cell |WuXi Advanced Therapies

It's no secret that on-going research aims to improve the efficacy and specificity of non-viral approaches for genetic engineering. But the field is rapidly evolving with research aimed at improving transfection efficiency, targeting, and safety profiles of non-viral delivery systems. Join Cell & Gene Live to discuss the most notable approaches and recent breakthroughs as well as promising non-viral vectors used in clinical trials. Attendance is free thanks to the support of MaxCyte.

Oct 22, 2024 | bioprocessonline.com | Joonman Hong |GC Cell |Junwei Sun |Lucia Fernandez |Lucia Fernández

Establishing Commercial Manufacturing Services For Antibody-Drug ConjugatesA significant portion of ADC projects are outsourced to CDMOs and with the continued expansion of pipelines and more commercial products reaching the market, CDMOs with plans to support commercial-scale ADC manufacturing need to invest in facilities and set up processes to handle complex supply chains and ensure efficiency, quality, and safety.

Sep 30, 2024 | cellandgene.com | Irwin Hirsh |Q-Specialists AB |Joonman Hong |GC Cell

Reserve your space for our Virtual Symposium on October 08! Moderated by Dr. Eleni Samaridou, Principal Scientist, Early Formulation Screening Service at MilliporeSigma, the symposium will feature Dr. Roland Böttger, Senior Scientist at CureVac, and other industry experts.

Aug 20, 2024 | bioprocessonline.com | Tyler Menichiello |Anjeanette Ormonde |Natasha Savage |Joonman Hong

Derisking Biomanufacturing: Why A CDMO In Poland Might Be Your Secret WeaponAs the U.S. government works to pass the BIOSECURE Act, which aims to the protect the IP of U.S. pharma companies, the EU is simultaneously seeking to increase innovation across the European biomanufacturing industry. Amid these cultural shifts, sponsors are considering the best global partnerships for their goals.